» Articles » PMID: 36962565

Knowledge and Attitudes About HIV Pre-exposure Prophylaxis: Evidence from In-depth Interviews and Focus Group Discussions with Policy Makers, Healthcare Providers, and End-users in Lesotho

Overview
Specialty Public Health
Date 2023 Mar 24
PMID 36962565
Authors
Affiliations
Soon will be listed here.
Abstract

Studies on knowledge and attitudes about HIV pre-exposure prophylaxis (PrEP) have mostly focused on key populations in North America and Europe. To inform Lesotho's national rollout of PrEP to the general population, this study aimed to characterize knowledge and attitudes about PrEP among policy makers, implementing partners, healthcare providers, and PrEP end-users in Lesotho. Respondents were purposively selected to participate based on personal experience in the development and implementation of Lesotho's PrEP program, or the personal use of PrEP. We conducted 106 in-depth interviews with policy makers (n = 5), implementing partners (n = 4), and end-users (current PrEP users = 55; former PrEP users = 36; and PrEP "decliners" = 6). In addition, we held 11 focus group discussions (FGDs) with a total of 105 healthcare providers. Interview and FGD transcripts were analyzed following the tenets of Grounded Theory. Respondents expressed positive attitudes toward PrEP, owing to experienced and perceived personal, familial, and societal benefits. PrEP was viewed as i) an opportunity for serodiscordant couples to remain together, ii) a means of conceiving children with minimized risk of HIV infection, iii) providing a sense of agency and control, and iv) an avenue for addressing the HIV epidemic in Lesotho. Respondents demonstrated understanding of PrEP's intended use, eligibility requirements, and modality of use. However, respondents also reported that several important misconceptions of PrEP were common among adults in Lesotho, including a belief that PrEP protects against sexually transmitted infections other than HIV, promotes promiscuity, prevents pregnancy, causes seroconversion, and provides lifelong protection from taking the pill just once. In addition to building on the perceived advantages of PrEP to shape a positive message, Lesotho's national rollout of PrEP will likely benefit from a communication strategy that specifically addresses the common misconceptions of PrEP identified in this study.

Citing Articles

Knowledge and attitudes of HIV pre-exposure prophylaxis among nurses in South Africa.

Bailey V, Kleinhans A, Mokgatle M Afr J Prim Health Care Fam Med. 2023; 15(1):e1-e6.

PMID: 37916728 PMC: 10698804. DOI: 10.4102/phcfm.v15i1.4086.


Preferences, educational messaging, and demand creation channels for multipurpose-prevention technologies (MPTs) among women in South Africa.

Mataboge P, Mthimkhulu N, Kutywayo A, Martin C, Mazibuko M, Kwatsha K BMC Public Health. 2023; 23(1):2090.

PMID: 37880628 PMC: 10598950. DOI: 10.1186/s12889-023-16904-0.


Stakeholder perspectives on interventions to improve HIV pre-exposure prophylaxis uptake and continuation in Lesotho: A participant-ranked preferences study.

Chebet J, McMahon S, Chase R, Tarumbiswa T, Maponga C, Mandara E PLOS Glob Public Health. 2023; 3(9):e0001423.

PMID: 37756319 PMC: 10529554. DOI: 10.1371/journal.pgph.0001423.


Motivations for pre-exposure prophylaxis uptake and decline in an HIV-hyperendemic setting: findings from a qualitative implementation study in Lesotho.

Chebet J, McMahon S, Tarumbiswa T, Hlalele H, Maponga C, Mandara E AIDS Res Ther. 2023; 20(1):43.

PMID: 37415180 PMC: 10324220. DOI: 10.1186/s12981-023-00535-x.


Cost-effectiveness of the dual prevention pill for contraception and HIV pre-exposure prophylaxis.

Milali M, Resar D, Kaftan D, Campbell J, Olowu A, Edwards D Front Reprod Health. 2023; 5:1144217.

PMID: 37266447 PMC: 10230827. DOI: 10.3389/frph.2023.1144217.

References
1.
Toledo L, McLellan-Lemal E, Henderson F, Kebaabetswe P . Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana. World J AIDS. 2016; 5(2):10-20. PMC: 4708891. DOI: 10.4236/wja.2015.51002. View

2.
Grov C, Whitfield T, Rendina H, Ventuneac A, Parsons J . Willingness to Take PrEP and Potential for Risk Compensation Among Highly Sexually Active Gay and Bisexual Men. AIDS Behav. 2015; 19(12):2234-44. PMC: 4560674. DOI: 10.1007/s10461-015-1030-1. View

3.
Ogunbajo A, Kang A, Shangani S, Wade R, Onyango D, Odero W . Awareness and Acceptability of pre-exposure prophylaxis (PrEP) among gay, bisexual and other men who have sex with men (GBMSM) in Kenya. AIDS Care. 2019; 31(10):1185-1192. PMC: 6663573. DOI: 10.1080/09540121.2019.1612023. View

4.
Ross I, Mejia C, Melendez J, Chan P, Nunn A, Powderly W . Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: Implications for country-wide implementation. PLoS One. 2017; 12(3):e0173057. PMC: 5336255. DOI: 10.1371/journal.pone.0173057. View

5.
Pilkington V, Hill A, Hughes S, Nwokolo N, Pozniak A . How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP. J Virus Erad. 2018; 4(4):215-224. PMC: 6248833. View